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Background: The prevalence of autism spectrum conditions (ASC) is 1% in developed countries, but little data are
available from mainland China, Hong Kong and Taiwan. This study synthesizes evidence relating to the prevalence
of ASC in these areas and assesses the effects of research methodology on prevalence estimates.
Methods: Systematic literature searches were conducted in PubMed, Web of Knowledge, China Web of Knowledge
and Weipu databases, as well as relevant papers published from 1987 to 2011, reporting prevalence estimates of
ASC or childhood autism in mainland China, Hong Kong and Taiwan. Summary estimates of prevalence were
calculated with a random effects model. The effects of research methodology on the prevalence estimates were
assessed using a meta-regression model.
Results: There were 25 studies eligible for review, 18 of which were suitable for inclusion in a meta-analysis. Pooled
prevalence of childhood autism was 11.8 per 10,000 individuals (95% confidence interval (CI): 8.2, 15.3) in mainland
China. Pooled prevalence of ASC was 26.6 per 10,000 (95% CI: 18.5, 34.6) in three areas. Substantial heterogeneity
was identified between studies (I2>75%). The prevalence estimate of childhood autism was most strongly
associated with the choice of screening instrument. After adjustment for age group, the odds ratio for prevalence
estimates when using the Autism Behavior Checklist (ABC) as the screening instrument compared with those using
the Clancy Autism Behavior Scale (CABS) was 0.29 (95% CI: 0.12, 0.69), and 1.79 (95% CI: 0.70, 4.55; P= 0.20) when
using the Checklist for Autism in Toddlers (CHAT) compared to the CABS.
Conclusions: The available studies investigating the prevalence of ASC in China, Hong Kong and Taiwan have
focused mainly on childhood autism rather than the whole spectrum. The prevalence estimates are lower than
estimates from developed countries. Studies using more recently developed screening instruments reported higher
prevalence than older ones. However, available studies have methodological weaknesses and therefore these
results lack comparability with those from developed countries. Our findings indicate a potential under-diagnosis
and under-detection of ASC in mainland China, Hong Kong and Taiwan, and a need to adopt more advanced
methods for research of ASC in these areas.
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Introduction
Autism spectrum conditions (ASC) are characterized by
impairments in social interaction and communication,
and the presence of repetitive and stereotyped behaviors,
interests and activities, and these impairments are present
during the life-course [1,2]. ASC are considered to have
a substantial functional and financial impact on affected
individuals and their families [3,4]. The first prevalence
estimate of autism, as described by Leo Kanner, was 4.5
per 10,000 people among children aged 8 to 10 in the
southeast of England [5]. There has been a rise in preva-
lence estimates reported in population-based studies in
developed countries. The most recent prevalence esti-
mate of ASC in the UK was 157 per 10,000 in 2009 [6]
and 113 per 10,000 in the US in 2012 [7]. In the East,
studies in Japanese populations showed that the preva-
lence of ASC increased from 21.1 per 10,000 in 1996 [8]
to 181 per 10,000 in 2008 [9]. A recent study in South
Korea reported a prevalence estimate of 264 per 10,000
in 2011 [10].
Several reasons have been proposed to the current
high prevalence, aside from a real increase: 1. the defin-
ition of autism has become broader [11]; 2. changes in
diagnostic criteria and possible diagnostic substitution
[12]; 3. changes in screening and diagnostic instruments
for case ascertainment [13]; 4. changes in research meth-
odology [14]; and 5. greater awareness and recognition
of ASC [15].
In the UK, the National Autism Plan for Children
(NAPC) was issued in 2003 [16], which listed strategies
for identification, assessment, diagnosis and access to
early intervention for preschool and primary school
children with ASC. In clinical settings, there are several
stages for diagnosing a child with suspected ASC. When
the child is being seen by a general practitioner for a
developmental assessment, the following examinations
should be included: 1. developmental history; 2. physical
examination; and 3. necessary and appropriate medical
investigations according to the clinical presentation of
the child. If during these examinations a diagnosis of
ASC is suspected, the child should be recommended to
the next stage, which is a multidisciplinary multiagency
assessment (MAA) [17]. The NAPC also recommended
that at least one team member should be trained in
using a standardized assessment tool, the Autism Diag-
nostic Observation Schedule [18] (ADOS) or the Aut-
ism Diagnostic Interview-Revised [19] (ADI-R).
In East Asia, autism was not recognized by researchers
until the early 1980s in mainland China [20,21]. Mainland
China has a large population of over 1.37 billion, however,
little is known about the extent of ASC in this country.
One published review [22] estimated that the prevalence
of childhood autism was 10.3 per 10,000 in mainlandChina, based on eight epidemiological studies. A recent
study reviewed the instruments used for case identification
of ASC in mainland China [23]. It indicated that the
Clancy Autism Behavior Scale (CABS) [24] and the Aut-
ism Behavior Checklist (ABC) [25] as screening instru-
ments, and the Childhood Autism Rating Scale (CARS)
[26] as a diagnostic instrument, were the most frequently
used in mainland China. The CABS was developed in
1969 [24] and introduced into China in the late 1980s.
There have been very few updates since it was first trans-
lated and validated. It has been widely used in epidemio-
logical research on childhood autism in mainland China,
however the data on its validity and reliability in the West
is lacking. The CABS was first published in 1969 [24].
However, there is no literature focusing on the utility of
the CABS in the Western population. The Chinese version
of the CABS was designed to be completed by parents. It
contains 14 items with each item rated on three frequency
levels including ‘never (score 0)’, ‘occasionally (score 1)’
and ‘often (score 2)’. If the child scores equal to or higher
than 14, and has less than 3 items score as ‘Never’ and
more than 6 items as ‘Often’, then the child should be con-
sidered as a potential case of childhood autism.
The CARS and ABC were also adopted early and are
still in use for ASC research in the West [27,28]. Simi-
larly, little is known about ASC in Hong Kong and
Taiwan. The prevalence estimates of ASC in China are
much lower than those from developed countries. The
identification of ASC depends on autistic features shown
during social interaction and communication. The iden-
tified autistic features could be influenced by culture as
different cultures have different behavioral norms and
expectations [29]. The heterogeneity of behaviors among
individuals with ASC may relate to different phenotypes
of ASC [30]. Thus, studies focusing on behaviors related
to ASC should take cultural influence into consideration,
especially for cross-sectional studies, since there may be
an association between culturally influenced behaviors
and the genetic origin of different phenotypes of ASC
[31]. Cultural factors could affect the prevalence esti-
mates of the ASC which in turn could affect the direc-
tions of molecular genetic studies. In addition, previous
studies have reported that the screening and diagnostic
criteria used in mainland China may be different from
Western studies [22,23]. For example, one of the diagnostic
criteria used in mainland China is the Chinese Classification
of Mental Disorders (CCMD). The CCMD categorizes aut-
ism as a childhood psychiatric condition, the diagnostic do-
mains of which were similar to those in the Diagnostic and
Statistical Manual of Mental Disorders (DSM) and the Inter-
national Classification of Diseases (ICD). The CCMD-2 has
been in use since 1993 [32], while the CCMD-3 was is-
sued in 2001 (Additional file 1)[33]. This means that
the CCMD has not kept track with changes in DSM.
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studies on the prevalence of ASC in mainland China,
Hong Kong and Taiwan; 2. to assess the quality of this
research; and 3. to evaluate the effects of the chosen re-
search methodology on the prevalence estimates.
Method
Search strategy and selection criteria
A systematic review using PubMed, Web of Knowledge,
China Web of Knowledge and Weipu databases was
undertaken to identify any study in each database pub-
lished between 1987 to December 2011, in either English
or Chinese, reporting prevalence estimates of ASC or
childhood autism in mainland China, Hong Kong and
Taiwan. A search strategy was developed, with a compre-
hensive list of terms (Additional file 2), including those
relating to the condition (for example, ‘autism’, ‘autistic dis-
orders’, ‘autism spectrum’, ‘pervasive developmental disor-
ders’, ‘Asperger’), study type (for example, ‘prevalence’,
‘epidemiology’, ‘screening’) and location (for example,
‘China’, ‘Hong Kong’, ‘Taiwan’). In addition, the bibliogra-
phies of previous reviews were examined to identify pub-
lished prevalence studies [1,22,34]. All searches were
conducted twice. The literature search, data extraction
and quality assessment was undertaken by the first author.
Identified papers were examined against inclusion criteria
(Additional file 3). All the abstracts were reviewed and du-
plicates excluded. When it was not clear from the abstract
whether the paper should be included, the paper itself was
examined where possible. When the papers were not
available, the corresponding authors were contacted to ob-
tain the papers. If a paper provided prevalence estimates
for different age groups using different methods, it was
reported as separate studies due to the adoption of differ-
ent study methods.
Data abstraction
Following the removal of duplicates, the following vari-
ables were extracted from each paper: sample characteris-
tics (year of publication, sample age, sex, region, location),
sampling strategy, screening methods, diagnostic criteria,
response rate (of screening/diagnostic assessment) and
prevalence estimation measures.
Statistical analysis
Crude prevalence estimates, confidence intervals (CIs) and
study details were extracted from each paper where avail-
able. The identified studies were divided into two groups
based on diagnosis: 1. childhood autism, included all stud-
ies that had provided a prevalence estimate for childhood
autism, or autistic disorder; and 2) ASC, included all stud-
ies that estimated the prevalence for the whole autism
spectrum. Forest plots were drawn to visualize the extent
of heterogeneity among studies.A random effects meta-analysis was used to estimate
the overall prevalence and investigate the heterogeneity
between studies. CIs were calculated from the crude
prevalence estimates if not available. The extent of
heterogeneity was estimated by calculating I2 (values of
25%, 50% and 75%, representing low, medium and high
heterogeneity, respectively) [35]. The proportion of
between-study variance explained by the covariates was
estimated using adjusted R2values. Meta-regression was
used to estimate the effect of the following covariates on
the log odds of the outcome: age group, year of publica-
tion, publication period, area, sample source, sample
size, screening method, screening instrument, screening
informants, diagnostic tool, diagnostic criteria and diag-
nostic informant. Each covariate was included separately
and then a multivariable meta-regression model was
constructed including all covariates with a statistically
significant (P <0.05) association in the univariate analyses.Results
In the first search attempt, the literature search identi-
fied 196 papers after the first two steps and 12 papers
were identified after Step 3 in PubMed. In the Web of
Knowledge, the first two steps identified 83 papers and
13 were identified after Step 3. In total, 25 papers in-
cluding duplicates were further examined against inclu-
sion criteria. Seven papers met the inclusion criteria and
were selected for this review. The second search attempt
was conducted within the 196 papers in PubMed and 83
papers in Web of Knowledge, which assured the seven
papers selected and no other papers had been missed.
Within the Weipu database, search Step 1 identified
2,028 papers and Step 2 identified 51 studies for further
examination against inclusion criteria. Within the China
Web of Knowledge, search Step 1 identified 3,919 papers
and Step 2 identified 80 papers. Combining the papers
from both Chinese databases, after removal of the dupli-
cated papers, there were 15 papers in total identified
according to the inclusion criteria for this review. The
second search within the two Chinese databases was
conducted to reassure the select results. Another four
papers were further identified which were not in the first
literature search result. In total, 19 papers were identi-
fied from Chinese databases. In parallel, eight studies
were identified from previous reviews.
After the removal of duplicates between Chinese and
English databases, a total of 25 studies were identified for
analyses (Figure 1). One paper reported two prevalence
studies within two different age groups using different
methodologies. This paper was considered as two studies
in the following analyses [36]. There were 21 studies
conducted in mainland China, two studies in Taiwan and
one study in Hong Kong (Table 1). In all of the studies,
Figure 1 Flowchart for selection of studies. Description of search process and results of the four databases.
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the Chinese population was generally unavailable.
The population size of the reviewed studies ranged
from 660 to 4,247,206 with a median sample size of
7,238 people. Two studies aimed to represent the whole
area of Hong Kong [49] and Taiwan [59], while one
study was generated from the national survey for dis-
ability in mainland China [58]. The age of participants
included in the studies mainly ranged from 0 to 17 years,
of which 23 studies focused on children aged 0 to 6 years
and 12 studies on children aged 6 to 14 years (Additional
file 4).
There were four sample sources: 1. clinical case counting
of outpatients referred to psychological hospitals, two
studies [37,42]; 2.case counting from hospital records in
the national health system, two studies [49,59]; 3. ran-
dom selection from local kindergartens, five studies
[39,46,51,56] and one sample was from primary schools
[48]; and 4.random selection from the general popula-
tion, 14 studies selected using a two-stage approach.
The first stage was stratification of the general popula-
tion followed by randomized sampling from the strati-
fied sample. There were five methods of sampling
including case counting, randomized sampling, whole
sample, clustered probability sampling and cluster-
randomized sampling (Additional file 5).
Other than three studies which did not conduct
screening but instead identified cases from existing
health records [37,49,59], screening was conducted
using the following approaches: 1. prospective screening
in clinics (n = 1) [42]; 2.face-to-face interviews with aquestionnaire (n = 19); 3.postal questionnaires (n = 1)
[55]; and 4.postal questionnaires followed by face-to-
face interviews (n = 1) [54].
Five studies conducted a second screening phase, while
17 studies only conducted one screening phase. Within
the first screening phase, four instruments were used
including the CABS (n = 15) [24], the ABC (n = 3)[60],
the Checklist for Autism in Toddlers (CHAT) (n = 3) [13]
and the Autism Spectrum Disorder in Adults Screening
Questionnaire (ASDASQ) (n = 1) [61]. Three studies used
the ABC and two used the CARS as screening tools after
the first screening phase [26].
In the diagnostic phase, studies generally did not
provide details about the diagnostic procedure. Three
studies considered the screening results to be the final
diagnosis without any additional diagnostic assessment
[37,49,59]. Twelve studies reported that the diagnosis
was made according to clinical judgment using inter-
national diagnostic criteria without using any diagnos-
tic instrument [37,38,40,42,46,48,51,54,56-59]. Twelve
studies adopted the CARS as the diagnostic instrument
[36,39,41,43-45,50,52,53,55,62], and one study adopted
both the CARS and the ADI-R [49,63]. Thirteen stud-
ies confirmed the diagnosis by clinicians conducting an
interview with the parents or caregivers, of which 11
studies reported the interrater agreement between the
clinicians using the kappa measure of agreement
[36,38,39,43-45,50,52,53,55,62], while the others used
percentage agreement (Additional file 6).
Six different types of diagnostic criteria were used for
case ascertainment which determined a prevalence
Table 1 Summary of prevalence studies of autism spectrum conditions in mainland China, Hong Kong and Taiwan (25 studies)
Year First
author
Region Sample
size
Area Age
(years)
Sample
screened
Screen
methods
Screen
tools
Cut-
off
Response
rate (%)
P/R Diagnostic
tools
Diagnostic criteria Childhood autism ASC
prevalence/SE
(per 10,000)
prevalence/SE
(per 10,000)
1987 Tao [37] Mainland 457,200 Urban 3 to 8 C R - - - R - Rutter 0.32 (0.08) -
2000 Luo [38] Mainland 10,802 Mixed 2 to 14 SG QI ABC 31 100 P - CCMD-2-R, DSM-III-R 2.8 (1.60) -
2002 Wang [39] Mainland 3.978 Urban 2 to 6 K QI CABS 7 98.3 P CARS CCMD-2-R 17.9 (6.70) -
2002 Ren [40] Mainland 3,559 Urban 3 to 5 SG QI CABS 14 99.1 P - - 250 (2.31) -
2003 Wang [41] Mainland 7,488 Mixed 2 to 6 SG QI CABS 7 98.08 P CARS CCMD-2-R 12.3 (4.05) -
2003 Chang [42] Taiwan 660 Mixed 15 to 93 C C ASDASQ 5 100 P - DSM-IV - 60.0 (30.06)
2004 Guo [43] Mainland 5,000 Urban 0 to 6 WP QI CABS 7 99.1 P CARS CCMD-2-R 10 (4.47) -
2004 Guo [44] Mainland 3,776 Rural 2 to 6 SG QI CABS 7 100 P CARS DSM-IV 8 (4.59) -
2005 Zhang [45] Mainland 7,416 Urban 2 to 6 SG QI CABS 7 99 P CARS DSM-IV 11.0 (3.85) -
2005 Zhang [46] Mainland 1,305 Urban 3 to 7 K QI CABS 14 100 P - - 19.9 (2.47) -
2005 Liu [47] Mainland 21,866 Mixed 2 to 6 SG QI CABS 7 100 P CARS DSM-IV 13.4 (2.47) 15.3 (2.64)
2007 Yang [48] Mainland 10,412 Urban 3 to 12 PS QI ABC 31 100 P - DSM-IV 5.6 (2.32) -
2007 Wong [49] Hong Kong 4,247,206 Mixed 0 to 14 HS R - - - R CARS, ADI-R DSM-IV - 16.1 (0.19)
2008 Zhang [36] Mainland 8,681 Urban 2 to 3 SG QI CHAT - 100 P CARS DSM-IV 16.1 (4.3) -
2008 Zhang [36] Mainland 12,430 Urban 4 to 6 SG QI CABS 14 100 P CARS DSM-IV 8.85 (2.7) -
2009 Zhang [50] Mainland 5,000 Urban 0 to 6 SG QI CABS 7 99.98 P CARS CCMD-2-R 10.0 (4.47) -
2009 Wang [51] Mainland 4,156 Urban 2 to 6 K QI CABS 14 100 P - - 19.5 (6.84) -
2010 Li [52] Mainland 8,006 Mixed 1.5 to 3 SG QI CHAT - 92.99 P CARS DSM-IV 26.2 (5.71) -
2010 Wu [53] Mainland 8,532 Urban 0 to 3 SG QI CHAT - 100 P CARS DSM-IV 8.2 (3.10) -
2010 Yu [54] Mainland 7,059 Mixed 2 to 6 SG Q CABS 7 89.7 P - DSM-IV 21.2 (5.47) 22.7 (5.66)
2010 Chen [55] Mainland 7,034 Mixed 2 to 6 SG Q CABS 7 98.78 P CARS DSM-IV 14.2 (4.49) 24.2 (5.86)
2011 Wang [56] Mainland 7,500 Urban 2 to 6 K QI CABS 14 87.8 P - DSM-IV 29.5 (6.26) 75.4 (9.99)
2011 Liang [57] Mainland 2,485 Urban 3 to 6 K QI CABS 14 100 P - DSM-IV, ICD-10 14.1 (7.53) -
2011 Li [58] Mainland 616,940 Mixed 0 to 17 SG QI ABC - - P - ICD-10 2.38 (0.20) -
2011 Chien [59] Taiwan 372,642 Mixed 0 to 17 HS R - - - R - ICD-9 - 28.7 (0.88)
Sample screened: C, clinical patients; HS, population in health system; K, kindergartens; PS, primary schools; SG, stratified general population; WP, whole population. Screen methods: C, clinical referral; Q,
questionnaire distribution; QI, questionnaire-based interview; R, records. Screen tools: ABC, Autism Behavior Checklist; ASDASQ, Autism Spectrum Disorder in Adults Screening Questionnaire; CABS, Clancy Autism Behavior
Scale; CARS, Childhood Autism Rating Scale; CHAT, Checklist for Autism in Toddlers. P, Perspective; R, Retrospective. Diagnostic criteria: ADI-R, Autism Diagnostic Interview-Revised; CCMD-2-R,Chinese Classification of
Mental Disorders, 2nd edition, revised; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; ICD-9,
International Classification of Diseases, 9th revision; ICD-10, International Classification of Diseases, 10th revision.ASC, autism spectrum conditions; SE,: Standard error; -, data not available.
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Classification of Mental Disorders, 2nd edition, revised
(CCMD-2-R) (n = 5) [32]; 3. Diagnostic and Statistical
Manual of Mental Disorders, 3rd edition, revised (DSM-
III-R) (n = 1) [64]; 4. DSM-IV (n = 13) [65]; 5. Inter-
national Classification of Diseases, 10th revision (ICD-10)
(n = 2) [2]; and 6.International Classification of Dis-
eases, 9th revision (ICD-9) (n = 1).
Twenty-one studies reported response rates at the
screening phase. In the reviewed prospective studies, par-
ticipation rates in the diagnostic phase were not directly
reported, since these studies conducted the screening and
diagnosis during a single appointment. In these cases,
when the child scored above the cut-off on the screening
instrument, the diagnostic assessment was conducted im-
mediately. Therefore, these studies only reported the final
participation rate following the diagnostic phase. Where
no information was provided about the children who were
not assessed in the diagnostic phase, the participation rate
was assumed to be 100%, which assumes that all children
who screened positive completed a further diagnostic
assessment during the analysis.
Twenty-two studies provided prevalence estimates for
childhood autism. Seven studies provided prevalence es-
timates for ASC (Additional file 7), of which four stud-
ies also investigated the prevalence of other subtypes,
including atypical autism and pervasive developmental
disorder not otherwise specified (PDD-NOS) [54-56,62].
Eighteen studies conducted both screening and diagnos-
tic assessments for identifying cases of childhood autism
in mainland China (Figure 2). The pooled prevalence
estimate for childhood autism among these 18 studies
was 11.8 per 10,000 (95% CI: 8.2, 15.3). The pooled
prevalence estimate for ASC was 26.6 per 10,000 (95%
CI: 18.5, 34.6).
The heterogeneity of the prevalence estimates among
the 22 studies on childhood autism was very high
(I2 = 93.4%). In further analyses, four studies on child-
hood autism were excluded since one was case counting
of hospital records and three only conducted screening
without a diagnostic phase [40,46,51]. The heterogeneity
of 18 studies was reduced but still high (I2 = 83.7%). The
heterogeneity of the seven studies describing the preva-
lence of ASC was also high (I2 = 97.4%).
The pooled prevalence estimate increased over time. Be-
tween the years 2000 and 2004, the pooled prevalence esti-
mate was 8.5 per 10,000 (range: 3.0, 13.9), which increased
to 10.3 per 10,000 (range: 7.2, 13.4) between 2005 and 2009.
The estimate was the highest in the years 2010 to 2011 at
16.4 per 10,000 (range: 7.0, 25.7). The prevalence estimates
were higher when using the CABS (12.8 per 10,000) and the
CHAT (17.0 per 10,000) as screening instruments, rather
than using the ABC (2.4 per 10,000). The heterogeneity was
very low among studies using the ABC (I2= 0.0%) (Figure 3).Only the studies that conducted both screening and
diagnostic assessment for childhood autism were exam-
ined using meta-regression, since the recommended mini-
mum number of studies for inclusion in a meta-regression
analysis is ten [66]. There was a significant association be-
tween the use of screening instruments and the prevalence
of childhood autism (Table 2). The prevalence estimates
for childhood autism in studies using the ABC as the
screening instrument was 79% lower than those studies
using the CABS (odds ratio: 0.21; 95% CI: 0.11, 0.38;
P <0.001). The prevalence estimates from studies using
the CHAT were 25% higher than those using the CABS
(odds ratio: 1.25; 95% CI: 0.71, 2.21), but the CI was wide
and included 1.0.
In three age groups (<4, 4, >4 years old), the preva-
lence estimates in studies with children older than 4
years old were significantly lower than estimates in
younger children (odds ratio: 0.32; 95% CI: 0.16, 0.68).
However, this result is dependent on three very large
studies. If these three studies with the largest sample
size were excluded, this association was not observed
(P= 0.33). No significant association was observed be-
tween the prevalence estimate and group sample size
(≤5000, 5000 to 7500, >7500). No other covariates were
found to have a significant association with the preva-
lence estimates.
Among 18 studies focusing on childhood autism in
mainland China, the different choice of screening in-
struments explained 77% of the between-study variance
(R2 = 77%, I2= 45%) and the age group of the children
explained 56% (R2= 56%, I2 = 71%).
A meta-regression model was constructed which in-
cluded screening instrument and age group (Table 2). This
model explained much of the heterogeneity between the
studies (R2 = 81%, I2= 44%). In this model, after adjusting
for the age group, the odds ratio for ASC in studies using
the ABC as the screening instrument was 0.29 compared
with the CABS (95% CI: 0.12, 0.69; P = 0.009), whereas
studies using the CHAT had higher rates (odds ratio: 1.79;
95% CI: 0.70, 4.55; P = 0.20). After adjusting for the
screening instrument, age group no longer showed a
significant effect.
Discussion
Among reviewed studies, the covariate most strongly as-
sociated with variation in the prevalence estimates for
childhood autism was the choice of screening instrument.
The association between screening instrument and preva-
lence estimates has been investigated in Western studies
[67-69]. The ABC and CABS (which were developed in
the 1980s from the West) were introduced to Chinese aut-
ism research much earlier than the CHAT. In reviewed
studies, the studies using the ABC as the screening instru-
ment reported the lower prevalence estimates, while
Figure 2 Prevalence of childhood autism (n = 18). Dots indicate prevalence estimates in reviewed studies. Horizontal lines indicate 95% CIs.
Vertical line indicates pooled prevalence estimate in the meta-analysis. The heterogeneity of 18 studies was high (I2 = 83.7%). Prevalence
estimates were presented for each reviewed study on childhood autism with 95% CIs. Reviewed studies were divided into three groups
according to publication period: 2000 to 2004, 2005 to 2009 and 2010 to 2011. The pooled prevalence estimates for all reviewed studies and
studies in each period were generated by a random effect meta-analysis model. There is an increase in the pooled prevalence estimates of
childhood autism over time. CIs, confidence intervals.
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childhood autism. However, there have been only three
studies using either the ABC or the CHAT to date. The
comparison of the effect of screening using the ABC or
the CHAT on the prevalence estimates is therefore lim-
ited. In this review, the age group of the children screened
was also found to be strongly associated with the preva-
lence estimate. Fifteen studies focused on children aged
between 2 to 6 years, six studies examined children aged
between 6 and 14, and only one study investigated the
population older than 14 years old. Most of the reviewed
studies included children who were as young as 2 to 3
years old. However, as the average age of diagnosis of ASC
is suggested to be 41 to 60 months [70], it was not unex-
pected that the prevalence estimate of children in this age
range would be relatively lower. However, this association
disappeared when adjusting for the screening instrument.
This may be due to the fact that recently developed
screening instruments have specifically determined age
ranges, while older measures included participants with a
wider age range. After adjusting for age group, the preva-
lence estimates for childhood autism generated from stud-
ies using the ABC as the screening instrument was 70%lower than those using the CABS, and the prevalence esti-
mates in studies using the CHAT was 80% higher than
those using the CABS.
The multi-regression model including the age group
and screening instrument explained the most among-
study variation in studies of childhood autism. The
effect of screening instrument was significant. This find-
ing suggested that it may be possible that the adoption
of screening instruments influenced the prevalence esti-
mates. The studies using the more recently developed
screening instrument (the CHAT) reported higher
prevalence than studies using other instruments (the
CABS and ABC). The CHAT is designed to screen
children for autism spectrum, and the CABS and ABC
are developed to detect children with one subtype of
ASC, childhood autism. This may be one of the reasons
why the prevalence estimates from studies using the
CHAT were higher than the CABS and ABC. In addition,
half of the reviewed studies did not use any diagnostic
instrument and the rest used the CARS as the diagnostic
instrument. There was a lack of comparability in the con-
firmation of case status between Chinese and Western
studies. As there were only a limited number of studies
Figure 3 Prevalence estimates of childhood autism and screening instruments (n = 18). Dots indicate prevalence estimates in reviewed
studies. Horizontal lines indicate 95% CIs. Vertical line indicates pooled prevalence estimate in the meta-analysis. The heterogeneity among
studies using the CABS and ABC is low. The pooled prevalence estimates of studies using the ABC as the screening instrument is the lowest,
while those using the CHAT reported the highest prevalence. ABC, Autism Behavior Checklist; CABS, Clancy Autism Behavior Scale; CHAT,
Checklist for Autism in Toddlers; CIs, confidence intervals.
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conducted to investigate whether this effect still exists
when using standardized diagnostic instruments for case
confirmation using different screening instruments in the
same population. It is important to note that the CHAT
misses as many cases as it detects and that a revised ver-
sion of this instrument, the Q-CHAT, is being evaluated
to improve the instrument (Allison et al, 2008).
In addition, there are other differences between studies
in developed countries and the reviewed studies. These
differences include the following factors. 1. Population
characteristics, due to missing information of the target
population it is difficult to evaluate the generalizability of
the sample for a whole area in mainland China and make
comparisons to other countries. In addition, service de-
velopment for special education and healthcare systems
were different in mainland China, Hong Kong and
Taiwan. 2. Administration of screening by face-to-face
interview is not common in studies in developed coun-
tries; many identified studies in this review were based
on samples from the stratified general population, while
large population-based studies in developed countries
used whole population distribution of a screening ques-
tionnaire [6]. Screening using two instruments is notcommon in studies in developed countries and which
instrument was administrated first was not clear in
these reviewed studies. If a second screening test is ap-
plied only to screen positives following the first screen-
ing, it is generally considered to increase the specificity
by reducing the false-positives compared with a single
test [71]. If the two screenings were done simultan-
eously, this might lead to higher sensitivity, since the
children that had been missed by the first screening in-
strument may have been identified to be at risk for ASC
by the second screening instrument [72]; the cut-off of
the same screening instruments varied among studies.
3. In the diagnostic phase, four prospective studies con-
sidered the screening results to be the diagnostic results;
standardized diagnostic instruments were not adopted
in reviewed studies; information on the reliability and
quality control of the diagnostic process was generally
lacking and assessors were not blind to the screen status
of the children when making a diagnostic evaluation;
and children whose screen results were negative were
not given a diagnostic assessment.
Despite the differences discussed above, other factors
related to autism in the Chinese population should also
be considered when examining prevalence estimates.
Table 2 Results of meta-regression childhood autism (18 studies)
Univariate analyses
Covariate Categories of covariate Number of studies Odds ratio 95%CI P value Variance explained (%)
No covariates 18
Year (continuous) 18 1.04 (0.93, 1.17) 0.43 −5.09
Year (categorical) 2000 to 2004 5 1.00 - - −10.92
2005 to 2009 6 1.13 (0.42, 3.08) 0.80
2010 to 2011 7 1.44 (0.55, 3.77) 0.43
Age group <4 5 1.00 - - 56.00
4 8 1.06 (0.56, 2.02) 0.84
>4 5 0.33 (0.16, 0.68) 0.005
Area Urban 9 1.00 - - −8.40
Mixed or rural 8 0.81 (0.38, 1.75) 0.57
Rural 1 0.64 (0.09, 4.37) 0.62
Sample group ≤5000 5 1.00 - - 7.43
5000 to 7500 5 1.43 (0.54, 3.80) 0.44
>7500 8 0.74 (0.30, 1.80) 0.48
Sample source Population-based 13 1.00 1.00 −0.19
Schools or kindergartens 4 1.44 (0.60, 3.48) 0.39
Screening method Interview 15 1.00 - - −0.89
Questionnaire 2 1.64 (0.54, 4.98) 0.36
Screening tool CABS 12 1.00 - 76.99
ABC 3 0.21 (0.11, 0.38) <0.001
CHAT 3 1.25 (0.71, 2.20) 0.42
Time Once 13 1.00 1.00 −2.10
Twice 4 1.40 (0.60, 3.27) 0.41
Screening informant Clinician 8 1.00 - - −13.86
Parent 3 0.93 (0.31, 2.75) 0.88
Research 6 0.90 (0.38, 2.10) 0.79
Diagnostic criteria CCMD-2-R 5 1.00 - - −5.34
DSM-III-R/DSM-IV/ICD-10 12 1.23 (0.52, 2.87) 0.62
Diagnostic tool None 6 1.00 - 2.54
CABS 11 1.51 (0.71, 3.21) 0.27
Diagnostic informant Clinician 13 1.00 - - 8.19
Researcher 4 0.47 (0.19, 1.17) 0.10
Multivariable analyses
Age group <4 5 1.00 - - 80.7
4 8 1.61 (0.68, 3.81) 0.26
>4 5 1.03 (0.34, 3.04) 0.96
Screening tool CABS 12 1.00 1.00 -
ABC 3 0.29 (0.12, 0.69) 0.009
CHAT 3 1.79 (0.70, 4.55) 0.20
ABC, Autism Behavior Checklist; CABS, Clancy Autism Behavior Scale; CCMD-2-R, Chinese Classification of Mental Disorders, 2nd edition, revised; CHAT, Checklist
for Autism in Toddlers; CI, confidence interval; SM-III-R, Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised; DSM-IV, Diagnostic and
Statistical Manual of Mental Disorders, 4th edition; ICD-10, International Classification of Diseases, 10th revision;-, data not available.
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http://www.molecularautism.com/content/4/1/7For example, one factor might be the awareness and
recognition of ASC among clinicians. One study investi-
gated awareness among Chinese community physicians,
comprehensive hospital pediatricians and parents who
were referred to the hospital in Wuxi city [36]. Results
indicated parents were the most knowledgeable about
the diagnosis of autism compared to pediatricians and
physicians. A recent review on healthcare and service
provision of ASC in mainland China suggested lower
awareness and lack of training in diagnosis of ASC
among Chinese clinicians [73]. Another factor might be
the lack of knowledge and acceptance of ASC among
Chinese parents. Studies on service provision of ASC in
mainland China found an unwillingness to accept the
diagnosis of ASC among Chinese parents [74]. This may
also influence the case identification of prevalence stud-
ies since it was mainly the parents who filled in screen-
ing and diagnostic questionnaires. A third factor might
be the potential cultural influence. People with disabil-
ities usually experience stigma, stemming from within
and outside the family influenced by societal beliefs
[75]. As autism is a condition categorized into the discip-
line of psychiatry, many informants in this sample (espe-
cially the older generation) considered it at best as not
good, and at worst as very bad. Previous studies reported
that family members may feel ashamed and embarrassed
by their children which can trigger stigma, which can also
lead to the difficulty in acceptance of the diagnosis of ASC
[76]. Meanwhile, the recognition of autistic features in one
culture may be different from another, since each culture
has a specific set of behavioral norms and expectations,
which are not necessarily the same as the others [29].
Thus, the interpretation of behavioral descriptions on
screening and diagnostic instruments can be different
among cultures. This may lead to possible differences in
the recognition of autistic behaviors between Chinese and
Western populations. Previous studies have suggested
possible different perceptions of eye contact [29] and the
age of speaking among boys [77]. Therefore, although it
was not possible to investigate these factors in this review,
the potential effects of these factors towards prevalence
estimation should not be ruled out when comparing be-
tween Chinese and Western populations.
There are several limitations of this review. First, the studies
reviewed were selected from two English and two Chinese da-
tabases, and no other databases were searched. It is possible
that studies that were published in Master’s or doctoral theses
in Hong Kong or Taiwan were not included and papers that
were not published in mainstream journals were not identified,
which may have reported different results. However, the four
databases were searched systematically using a consistent ap-
proach with a second attempt of one-by-one checking. Thus,
it is unlikely that the reviewed papers are biased with respect
to prevalence estimates reported. The number of studiesincluded in the meta-analysis was limited, with only 18 for
childhood autism and seven for ASC. Meta-regression of stud-
ies for ASC was not conducted due to the limited number of
available studies. Due to the limited number of studies avail-
able for regression analysis, the potential association between
the age group and the choice of screening instrument was not
further investigated in this review. Thus, the generalization of
the results is limited and the interpretations of these results
need to be considered carefully. There were a limited number
of studies conducted in Hong Kong and Taiwan. Due to the
differences among regions, caution should be employed
when applying the results from mainland China to Hong
Kong and Taiwan. The coding approach of covariates may
have affected the detected association with prevalence es-
timates, such as the approach of categorizing the diagnos-
tic criteria and using the age groups. Since information on
the process of screening and diagnosis was often missing,
an assumption was made about the participation rate in
the assessment phase. It would be helpful to have further
information about the details where this information was
missing. Only the impact of quantifiable covariates on
prevalence estimates was assessed in this review. Potential
qualitative influences on prevalence such as public aware-
ness and the recognition of ASC were not included.Conclusion
This review revealed major differences in research method-
ology for estimating prevalence between the developed coun-
tries and mainland China, Hong Kong and Taiwan. In the
future, in order to make comparisons between studies cross-
culturally, it would be valuable to validate more recently pub-
lished screening instruments for ASC used in Western
countries in these three areas. Standardized diagnostic instru-
ments including the ADOS [78] and ADI-R need to be
adapted and validated in the Chinese population to make ro-
bust comparison possible. The Chinese versions of these two
instruments have been approved by the publisher, Western
Psychological Services (WPS). More recently, in 2012, a new
updated version of the Chinese ADI-R has been finalized by
the WPS. Three screening instruments have been validated
in the Chinese population in Taiwan including the Social
Communication Questionnaire (SCQ) [79], the Social
Responsiveness Scale (SRS) [80] and the Autism Spectrum
Quotient (AQ) [81]. Another screening instrument, the
Childhood Autism Spectrum Test (CAST) [82] has been val-
idated in mainland China. Since the CCMD was developed
and only used in mainland China, a more universal and
standardized diagnostic process for ASC should be adopted
for autism research in Chinese populations. Prospective
population-based epidemiological studies of ASC need to be
conducted in mainland China, Hong Kong and Taiwan using
methods which are comparable across the Chinese popula-
tion and with the rest of the world.
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